{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T23:51:39Z","timestamp":1792281099191,"version":"4.4.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012544","name":"China Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-115-012"],"award-info":[{"award-number":["DMR-115-012"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-114-080"],"award-info":[{"award-number":["DMR-114-080"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-HHC-114-10"],"award-info":[{"award-number":["DMR-HHC-114-10"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU114-ASIA-12"],"award-info":[{"award-number":["CMU114-ASIA-12"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU112-ASIA-08"],"award-info":[{"award-number":["CMU112-ASIA-08"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.dsx.2026.103402","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T07:17:30Z","timestamp":1774250250000},"page":"103402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["People living with diabetes with sodium-glucose cotransporter-2 inhibitors use are at an increased risk of future total knee joint replacement"],"prefix":"10.1016","volume":"20","author":[{"given":"Wei-Syun","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.dsx.2026.103402_bib1","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"EMPEROR-reduced trial investigators. Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.dsx.2026.103402_bib2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ejhf.1432","article-title":"DAPA-HF committees and investigators. A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)","volume":"21","author":"McMurray","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.dsx.2026.103402_bib3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00210-023-02623-1","article-title":"Psychiatric disorders in patients with type 2 diabetes mellitus on sodium-glucose cotransporter-2 inhibitors-a nationwide retrospective cohort study","volume":"397","author":"Hu","year":"2024","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"10.1016\/j.dsx.2026.103402_bib4","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00210-023-02685-1","article-title":"Sodium-glucose cotransporter-2 inhibitor in risk of sepsis\/septic shock among patients with type 2 diabetes mellitus-a retrospective analysis of nationwide medical claims data","volume":"397","author":"Hu","year":"2024","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.dsx.2026.103402_bib5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00210-024-03296-0","article-title":"Effect of anti-diabetic agent on interstitial lung disease in patients with diabetes mellitus","volume":"398","author":"Hu","year":"2025","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"10.1016\/j.dsx.2026.103402_bib6","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1007\/s00210-024-03553-2","article-title":"Beneficial effect of sodium-glucose cotransporter-2 inhibitors on mortality among patients with cancer and diabetes mellitus. Hu WS, lin CL","volume":"398","author":"Hu","year":"2025","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"Suppl","key":"10.1016\/j.dsx.2026.103402_bib7","article-title":"Associations of metabolic syndrome and its components with the risk of incident knee osteoarthritis leading to hospitalization: a 32-year follow-up study","volume":"13","author":"Konstari","year":"2021","journal-title":"Cartilage"},{"key":"10.1016\/j.dsx.2026.103402_bib8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.joca.2020.09.010","article-title":"Metabolic osteoarthritis: relation of diabetes and cardiovascular disease with knee osteoarthritis","volume":"29","author":"Kuusalo","year":"2021","journal-title":"Osteoarthr Cartil"},{"issue":"49","key":"10.1016\/j.dsx.2026.103402_bib9","doi-asserted-by":"crossref","first-page":"E1672","DOI":"10.1503\/cmaj.220952","article-title":"Metformin use and associated risk of total joint replacement in patients with type 2 diabetes: a population-based matched cohort study","volume":"194","author":"Zhu","year":"2022","journal-title":"CMAJ"},{"issue":"7","key":"10.1016\/j.dsx.2026.103402_bib10","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dsx.2026.103402_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111712","article-title":"Association of sodium-glucose cotransporter 2 inhibitor use with risk of osteoporotic fracture among older women: a nationwide, population-based cohort study","volume":"213","author":"Lee","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.dsx.2026.103402_bib13","article-title":"The association between diabetes mellitus and osteoarthritis: does diabetes mellitus play a role in the severity of pain in osteoarthritis?","volume":"14","author":"Chowdhury","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.dsx.2026.103402_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cger.2014.08.019","article-title":"Links between osteoarthritis and diabetes: implications for management from a physical activity perspective","volume":"31","author":"Piva","year":"2015","journal-title":"Review Clin Geriatr Med"},{"key":"10.1016\/j.dsx.2026.103402_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bone.2014.12.001","article-title":"AMP-Activated protein kinase (AMPK) activity negatively regulates chondrogenic differentiation","volume":"74","author":"Bandow","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.dsx.2026.103402_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1744-8069-8-5","article-title":"Resveratrol engages AMPK to attenuate ERK and mTOR signaling in sensory neurons and inhibits incisioninduced acute and chronic pain","volume":"8","author":"Tillu","year":"2012","journal-title":"Mol Pain"},{"issue":"6","key":"10.1016\/j.dsx.2026.103402_bib17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2215\/CJN.16171221","article-title":"Fracture risk of sodium-glucose Cotransporter-2 inhibitors in chronic kidney disease","volume":"17","author":"Cowan","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.dsx.2026.103402_bib18","article-title":"The extraglycemic effect of SGLT-2is on mineral and bone metabolism and bone fracture","volume":"13","author":"Dong","year":"2022","journal-title":"Review Front Endocrinol (Lausanne)"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402126000299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402126000299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:55:27Z","timestamp":1777593327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402126000299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1871402126000299"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2026.103402","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"People living with diabetes with sodium-glucose cotransporter-2 inhibitors use are at an increased risk of future total knee joint replacement","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2026.103402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103402"}}